NCT06083662 2025-03-18Neratinib and Trastuzumab Biosimilar in Patients with HER2 Mutated Advanced Solid CancersKorea University Guro HospitalPhase 2 Completed42 enrolled
NCT00838539 2018-09-18Study Evaluating Neratinib In Combination With Temsirolimus In Subjects With Solid TumorsPuma Biotechnology, Inc.Phase 1 Completed63 enrolled 26 charts
NCT00397046 2018-09-14A Study Of The Safety And Tolerability Of HKI-272 Administered Orally To Japanese Subjects With Advanced Solid TumorsPuma Biotechnology, Inc.Phase 1 Completed21 enrolled 13 charts